Company profile

EXINI Diagnostics AB

EXINI Diagnostics AB has 3 AI-enabled medical devices on the FDA list. The first decision was on August 5, 2019 and the most recent on April 29, 2022 (aPROMISE X). Its most common review panel is Radiology (3 devices).

3AI devices
2019First decision
2022Latest decision
1Specialties

Per year

2019: 12021: 12022: 1
201920212022
EXINI Diagnostics AB AI devices per year: 2019 1, 2021 1, 2022 1

By specialty

  • Radiology3

Related guides

Timeline

  1. aPROMISE X · Radiology · LLZ
  2. aPROMISE · Radiology · LLZ
  3. aBSI · Radiology · LLZ